Cargando…

Characteristics and outcomes of COVID-19 in patients with autoimmune bullous diseases: A retrospective cohort study

Detalles Bibliográficos
Autores principales:	Mahmoudi, Hamidreza, Farid, Ali Salehi, Nili, Ali, Dayani, Dorsa, Tavakolpour, Soheil, Soori, Tahereh, Teimourpour, Amir, Isazade, Ahdie, Abedini, Robabeh, Balighi, Kamran, Daneshpazhooh, Maryam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the American Academy of Dermatology, Inc. 2021
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836213/ https://www.ncbi.nlm.nih.gov/pubmed/33359593 http://dx.doi.org/10.1016/j.jaad.2020.12.043

Ejemplares similares

Estimated cut-off values for pemphigus severity classification according to pemphigus disease area index (PDAI), autoimmune bullous skin disorder intensity score (ABSIS), and anti-desmoglein 1 autoantibodies
por: Mohebi, Farnam, et al.
Publicado: (2020)

Infections in Hospitalized Patients with Psoriasis in a Skin Referral Hospital
por: Zaredar, Nafise, et al.
Publicado: (2023)

Exacerbation of Autoimmune Bullous Diseases After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Is There Any Association?
por: Kianfar, Nika, et al.
Publicado: (2022)

Autoimmune Bullous Disease Quality of Life (ABQoL) questionnaire: Validation of the translated Persian version in pemphigus vulgaris
por: Teimourpour, Amir, et al.
Publicado: (2020)

Acute generalized exanthematous pustulosis with a focus on hydroxychloroquine: A 10-year experience in a skin hospital
por: Nili, Ali, et al.
Publicado: (2020)

Short-term clinical and serological follow-up with conventional and conformational anti-desmoglein antibodies in treatment-naïve and previously treated patients with pemphigus vulgaris after receiving rituximab
por: Alaeen, Hoorieh, et al.
Publicado: (2019)

Frontal fibrosing alopecia: An update on the hypothesis of pathogenesis and treatment
por: Tavakolpour, Soheil, et al.
Publicado: (2019)

Family impact of pemphigus disease in an Iranian population using the Family Dermatology Life Quality Index
por: Ghodsi, S. Zahra, et al.
Publicado: (2020)

Generalized Pustular Psoriasis Flare-Up after Both Doses of BBIBP-CorV Vaccination in a Patient under Adalimumab Treatment: A Case Report
por: Dayani, Dorsa, et al.
Publicado: (2023)

Editorial: Challenges of COVID-19 in dermatology patients on immunosuppression: Risk, outcome, vaccination, and beyond
por: Mahmoudi, Hamidreza, et al.
Publicado: (2022)

Editorial: Challenges of COVID-19 in dermatology patients on immunosuppression: risk, outcome, vaccination and beyond, volume II
por: Patsatsi, Aikaterini, et al.
Publicado: (2023)

Dermoscopic Findings in 126 Patients with Alopecia Areata: A Cross-Sectional Study
por: Mahmoudi, Hamidreza, et al.
Publicado: (2018)

Effects of Nasal Calcitonin vs. Oral Gabapentin on Pain and Symptoms of Lumbar Spinal Stenosis: A Clinical Trial Study
por: Haddadi, Kaveh, et al.
Publicado: (2016)

Pregnancy outcomes in women with pemphigus exposed to rituximab before or during pregnancy
por: Dehghanimahmoudabadi, Azin, et al.
Publicado: (2022)

Indirect immunofluorescence on rat bladder epithelium in patients with pemphigus vulgaris with an extended follow‐up
por: Samadi, Mahsa, et al.
Publicado: (2022)

Cryotherapy plus oral zinc sulfate versus cryotherapy plus placebo to treat common warts: A double blind, randomized, placebo-controlled trial()()
por: Mahmoudi, H., et al.
Publicado: (2017)

Decreased Serum Levels of Interleukin-4 and Interleukin-21 in New Pemphigus Vulgaris Patients, but Not Chronic Patients With Inactive Disease Compared to Healthy Controls
por: Shahbazian, Pegah, et al.
Publicado: (2021)

Assessing quality of life in patients with autoimmune bullous diseases using the Persian version of Treatment of Autoimmune Bullous Disease Quality of Life questionnaire finds similar effects in women as men
por: Behkar, Atefeh, et al.
Publicado: (2022)

Anal Involvement in Pemphigus Vularis
por: Khezri, Somayeh, et al.
Publicado: (2013)

Dipeptidyl-Peptidase 4 Inhibitor-Induced Variants of Bullous Pemphigoid: A Case Series of Four Patients
por: Balighi, Kamran, et al.
Publicado: (2022)

The Autoimmune Bullous Diseases
por: Wakelin, S H, et al.
Publicado: (1997)

The potential roles of herpesvirus and cytomegalovirus in the exacerbation of pemphigus vulgaris
por: Mohammadi, Fariba, et al.
Publicado: (2018)

Rituximab therapy improves recalcitrant Pemphigus vulgaris
por: Noormohammadpour, Pedram, et al.
Publicado: (2015)

The first report of Pseudomonas oryzihabitansin infection in a patient with hidradenitis suppurativa
por: Keikha, Masoud, et al.
Publicado: (2019)

Therapy of autoimmune bullous diseases
por: Mutasim, Diya F
Publicado: (2007)

Autoimmune Bullous Disease in Childhood
por: Salman, Andac, et al.
Publicado: (2017)

COVID-19: The experience from Iran
por: Daneshpazhooh, Maryam, et al.
Publicado: (2021)

Koebner phenomenon in pemphigus vulgaris patients
por: Balighi, Kamran, et al.
Publicado: (2016)

Changes in induced regulatory T cells by interleukin 35 during atopic dermatitis
por: Tavakolpour, Soheil
Publicado: (2016)

The role of intravenous immunoglobulin in treatment of mucous membrane pemphigoid: A review of literature
por: Tavakolpour, Soheil
Publicado: (2016)

Dermoscopy of cutaneous granulomatous disorders: A study of 107 cases
por: Kalantari, Yasamin, et al.
Publicado: (2023)

Longitudinal melanonychia in an Iranian population: a study of 96 patients
por: Kamyab, Kambiz, et al.
Publicado: (2016)

Assessment of the quality of life of Egyptian and Tunisian autoimmune bullous diseases’ patients using an Arabic version of the autoimmune bullous disease quality of life and the treatment of autoimmune bullous disease quality of life questionnaires
por: Saleh, Marwah Adly, et al.
Publicado: (2019)

Immunopathology and molecular diagnosis of autoimmune bullous diseases
por: Mihai, Sidonia, et al.
Publicado: (2007)

BP180 Is Critical in the Autoimmunity of Bullous Pemphigoid
por: Liu, Yale, et al.
Publicado: (2017)

The Role of Mast Cells in Autoimmune Bullous Dermatoses
por: Yu, Xinhua, et al.
Publicado: (2018)

Humoral Epitope Spreading in Autoimmune Bullous Diseases
por: Didona, Dario, et al.
Publicado: (2018)

Ocular Manifestations and Management of Autoimmune Bullous Diseases
por: Feizi, Sepehr, et al.
Publicado: (2019)

Advanced Diagnostic Techniques in Autoimmune Bullous Diseases
por: Jindal, Anuradha, et al.
Publicado: (2017)

Serological Diagnosis of Autoimmune Bullous Skin Diseases
por: Saschenbrecker, Sandra, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3crlc301q6766k0ckp067c7bes